Phase I study on patients with oxi refractory/intolerant KRAS mutant CRC

coloCan Member Posts: 1,944 Member
edited March 2014 in Colorectal Cancer #1
announced this date by Calgary, Canada-based Oncolytics Biotech, which will consist of FOLFIRI (Leucovorin,5FU and Irinotecan)with this new thing called Reolysin (REO). For more info see or

Hope this helps someone